As a pilot fellowship scheme, the SAFE project offers 60 fully-funded fellowships (up to 24 months) for doctoral and postdoctoral researchers of any non-EU nationality to work at a research institution in the EU. More information here.
Prof. Devrim Gözüacik Thursday, December 12th 2024, at 13:00, CET The role of autophagy in cancer biology and implications for cancer treatment Professor Devrim Gozuacik obtained his Medical Doctor (MD) degree from Hacettepe School of Medicine in Ankara, his MS degree of Biochemistry from Ecole Polytechnique, Paris and his PhD degree of cancer cell biology
PROTEOCURE WEBINAR Read More »
Dr. Ayala Shiber Thursday, November 14th 2024, at 13:00, CET A novel quality control pathway on the ribosome dedicated for co-translational protein complex-assembly Dr. Shiber is an Assistant Professor at the Biology faculty, Technion-Israel Institute of Technology since 2019. Her main research objective is to resolve the long-standing questions: How do cells direct their proteome
PROTEOCURE WEBINAR Read More »
Dr. Moe Abbas Thursday, November 7th 2024, at 13:00, CET An Oxygen Sensing Mechanism for Altitude Adaptation in Plants Dr. Moe Abbas is a Lebanese scientist whose research focusses on understanding multi-stress resilience across geographical niches in plants. Dr. Abbas obtained his doctorate from the Universidad Politecnica de Valencia (IBMCP-UPV) in 2014, working with Professors
PROTEOCURE WEBINAR Read More »
Nuray ERIN Thursday, October 10th 2024, at 13.00 CET Cancer neuro-environment Prof. Erin was graduated from Medical School in Marmara University in 1995. She continued her studies in Penn State University Hershey PA and received her doctorate degree in June 2001 in Pharmacology. She studied interactions between Bcl-2 and calcineurin as part of her Ph.D thesis
PROTEOCURE WEBINAR Read More »
Announcement of a Collection on Targeted Protein Degradation Submission deadline: 21 February 2025 Editors “In this Collection, we invite submissions focused on the design, development, and application of TPD modalities. Submissions are not only limited to PROTACs, and we encourage the submission of manuscripts containing new TPD modalities. For example, we welcome new methods exploiting
Targeted Protein Degradation Read More »
Shalini Padmanabhan Thursday, September 19th 2024, at 13.00 CET The Michael J. Fox Foundation’s Research Strategy Shalini Padmanabhan is Vice President of Discovery and Translational Research at The Michael J. Fox Foundation for Parkinson’s Research. At the Foundation, she oversees a team of 8 other scientists and over 400 active projects focusing on the biological understanding
PROTEOCURE WEBINAR Read More »
Prof. Michael Rape Thursday, October 3rd 2024, at 5:30 PM, Paris time (8:30 AM PST) From basic biology to new therapies: protein degradation in stress signaling Prof. Michael Rape is investigator with HHMI, the Dr. K. Peter Hirth Chair of Cancer Biology, and Professor of Cell and Developmental Biology, UC Berkeley. Link to Michael Rape’s
PROTEOCURE WEBINAR Read More »
